l 012

L 012 is a bioactive chemical.

L 012 sodium salt, a luminol analogue, is a widely used chemiluminescent (CL) probe for active oxygen and active nitrogen. L 012 sodium salt is widely used to detect the superoxides (O2•−) derived from NADPH oxidase (Nox) to find Nox inhibitors.

2-Amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert butyl ester 3-ethyl ester ,with CAS No. 193537-14-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 2-Amino-4,7-dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert butyl ester 3-ethyl ester provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

7-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one ,with CAS No. 22245-92-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 7-Amino-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0120, with CAS No. 22246-76-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0120 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0123, with CAS No. 635712-88-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0123 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0124, with CAS No. 1190971-73-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0124 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0125, with CAS No. 179950-69-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0125 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0126, with CAS No. 5444-61-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0126 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0127, with CAS No. 40769-81-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0127 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0128, with CAS No. 887625-09-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0128 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Tapencarium (RZL-012) is a serine/threonine kinase inhibitor that reduces subcutaneous fat volume. It holds potential for research into fat-related conditions, including Dercum's disease and cosmetic uses.

MCL0129, a selective and non-peptidergic melanocortin 4 (MC4) receptor antagonist, is a potential treatment for cachexia.

BXL0124 is a gemini vitamin D analog which targets CD44-STAT3 signaling and inhibits breast cancer invasion.

16:0-18:1 Diether PG is a type of glycerophospholipid where a hexadecyl chain and an octadecenyl chain are connected via ether bonds to the glycerol backbone at the sn-1 and sn-2 positions, respectively. 16:0-18:1 Diether PG is utilized in the preparation of liposomes.

Palm oil is a type of palm oil that can serve as a carrier for active molecules.

DSPE-PEG2000-Azide ammonium is a lipid-based azide compound used in forming micelles for nanoparticle drug delivery. It serves as a click chemistry reagent and includes an azide group that reacts with molecules containing an alkyne group through a copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc). Additionally, it can engage in a strain-promoted azide-alkyne cycloaddition (SPAAC) with molecules containing DBCO or BCN groups.

08:0 PI ammonium is a glycerophospholipid featuring a head group that carries a cyclohexanol moiety.

C17 Lyso PAF (1-O-Heptadecyl-2-hydroxy-sn-glycero-3-phosphocholine) acts as a precursor and metabolite of 1-O-Heptadecyl-2-acetyl-sn-glycero-3-phosphocholine (C17:0 PAF).

IZS-M is an amino acid-derived corrosion inhibitor based on green chemistry principles. It prevents the corrosion of low carbon steel by forming an inhibitor film on the metal surface. The corrosion inhibition performance of the IZS series is as follows: IZS-P (82.46%) > IZS-M (67.19%) > IZS-L (24.77%).

(R)-WRN inhibitor 1 is the R-isomer of WRN inhibitor 1 (example 7). It functions as a WRN inhibitor with anticancer properties.

Biotin-16-dGTP tetralithium is a biotin-labeled dGTP used for tagging oligonucleotides.

Compound 708-14-5, with CAS No. 708-14-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 708-14-5 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound 5043-05-0, with CAS No. 5043-05-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound 5043-05-0 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.